FMP
TransMedics Group, Inc.
TMDX
NASDAQ
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
61.7 USD
1.17 (1.9%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Waleed H. Hassanein M.D.
sector
Healthcare
industry
Medical - Devices
website
https://www.transmedics.comexchange
NASDAQ
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of...
CIK
0001756262
ISIN
US89377M1099
CUSIP
89377M109
Address
200 Minuteman Road
Phone
978 552 0900
Country
US
Employee
584
IPO Date
May 2, 2019
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
TMDX Financial Summary
CIK
0001756262
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
89377M109
ISIN
US89377M1099
Country
US
Price
61.7
Beta
2.07
Volume Avg.
1.85M
Market Cap
2.07B
Shares
-
52-Week
59.722-177.37
DCF
-0.09
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
66.34
P/B
-
Website
https://www.transmedics.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest TMDX News
It looks like there's no news available.
